Abstract
Ben Goldacre's book, Bad Pharma: how drug companies mislead doctors and harm patients, is the latest of several books and articles in recent years to level criticisms at the way the pharma industry and regulatory authorities operate; criticisms that need to be taken seriously, revealing faults that need to be corrected. It makes uncomfortable reading. Goldacre chooses his targets well and shoots at them with well-documented examples, some of them truly shocking, many of them uncovered only after persistent and tenacious probing of reluctant sources. These are tales of secrecy, dishonesty, bribery and corruption that make for a compelling read, couched in prose reminiscent of scandalous revelations in the tabloid press. To the question of style, we will – as Goldacre himself so often says, to keep his readers hooked – come back later.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
